Clinical trials of live oral rotavirus vaccines: the Finnish experience
- 31 December 1993
- Vol. 11 (2), 255-261
- https://doi.org/10.1016/0264-410x(93)90026-t
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificityThe Pediatric Infectious Disease Journal, 1992
- Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus DiarrhoeaActa Paediatrica, 1991
- Rhesus Rotavirus Candidate VaccineAmerican Journal of Diseases of Children, 1990
- Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal EpisodesScandinavian Journal of Infectious Diseases, 1990
- Evaluation of RIT 4237 Bovine Rotavirus Vaccine in Newborn Infants: Correlation of Vaccine Efficacy to Season of Birth in Relation to Rotavirus Epidemic PeriodScandinavian Journal of Infectious Diseases, 1990
- Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccineThe Pediatric Infectious Disease Journal, 1987
- Protective effect of preexisting rotavirus‐specific immunoglobulin A against naturally acquired rotavirus infection in childrenJournal of Medical Virology, 1987
- Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemicThe Journal of Pediatrics, 1985
- A bovine rotavirus developed as a candidate vaccine for use in humansJournal of Biological Standardization, 1984
- PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINEThe Lancet, 1984